BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37376432)

  • 1. Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious.
    Akache B; Read AJ; Dudani R; Harrison BA; Williams D; Deschatelets L; Jia Y; Chandan V; Stark FC; Agbayani G; Makinen SR; Hemraz UD; Lam E; Régnier S; Zou W; Kirkland PD; McCluskie MJ
    Vaccines (Basel); 2023 May; 11(6):. PubMed ID: 37376432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and immunogenicity of novel bivalent virus-like particles bearing VP60 genes of classic RHDV(GI.1) and RHDV2(GI.2).
    Qi R; Miao Q; Zhu J; Tang J; Tang A; Wang X; Dong D; Guo H; Liu G
    Vet Microbiol; 2020 Jan; 240():108529. PubMed ID: 31902498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.
    Akache B; Renner TM; Tran A; Deschatelets L; Dudani R; Harrison BA; Duque D; Haukenfrers J; Rossotti MA; Gaudreault F; Hemraz UD; Lam E; Régnier S; Chen W; Gervais C; Stuible M; Krishnan L; Durocher Y; McCluskie MJ
    Sci Rep; 2021 Nov; 11(1):21849. PubMed ID: 34750472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
    Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ
    Front Immunol; 2023; 14():1182556. PubMed ID: 37122746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effects of interleukin-2 co-expression with VP60 in an oral vaccine delivered by attenuated Salmonella typhimurium against rabbit hemorrhagic disease.
    Deng Z; Geng Y; Wang K; Yu Z; Yang PO; Yang Z; He C; Huang C; Yin L; He M; Tang L; Lai W
    Vet Microbiol; 2019 Mar; 230():49-55. PubMed ID: 30827404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model.
    Jia Y; Akache B; Agbayani G; Chandan V; Dudani R; Harrison BA; Deschatelets L; Hemraz UD; Lam E; Régnier S; Stark FC; Krishnan L; McCluskie MJ
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Stark FC; Akache B; Ponce A; Dudani R; Deschatelets L; Jia Y; Sauvageau J; Williams D; Jamshidi MP; Agbayani G; Wachholz K; Harrison BA; Li X; Krishnan L; Chen W; McCluskie MJ
    Vaccine; 2019 Nov; 37(47):7108-7116. PubMed ID: 31383490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
    Akache B; Agbayani G; Stark FC; Jia Y; Dudani R; Harrison BA; Deschatelets L; Chandan V; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity in Rabbits of Virus-Like Particles from a Contemporary Rabbit Haemorrhagic Disease Virus Type 2 (GI.2/RHDV2/b) Isolated in The Netherlands.
    Miao Q; Qi R; Veldkamp L; Ijzer J; Kik ML; Zhu J; Tang A; Dong D; Shi Y; van Oers MM; Liu G; Pijlman GP
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31207978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccination with a gene encoding VP60 elicited protective immunity against rabbit hemorrhagic disease virus.
    Yuan D; Qu L; Liu J; Guo D; Jiang Q; Lin H; Si C
    Vet Microbiol; 2013 May; 164(1-2):1-8. PubMed ID: 23419819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
    Akache B; Jia Y; Chandan V; Deschatelets L; McCluskie MJ
    Methods Mol Biol; 2022; 2412():255-267. PubMed ID: 34918249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV.
    DeSheng K; HuaiRan L; JiaSen L; Zuo Y; Qian J; DongChun G; XiaoLiang H; FengJie W; QianQian H; LianDong Q
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):5951-66. PubMed ID: 25895085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening optimal DC-targeting peptide to enhance the immune efficacy of recombinant
    Xia T; Lu X; Kong D; Guo T; Gao Y; Xin L; Jiang Y; Wang X; Shan Z; Li J; Zhou H; Cui W; Qiao X; Tang L; Li Y; Wang L
    Virulence; 2024 Dec; 15(1):2368080. PubMed ID: 38899573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
    Jia Y; Chandan V; Akache B; Qian H; Jakubek ZJ; Vinogradov E; Dudani R; Harrison BA; Jamshidi MP; Stark FC; Deschatelets L; Sauvageau J; Williams D; Krishnan L; McCluskie MJ
    J Liposome Res; 2021 Sep; 31(3):237-245. PubMed ID: 32583693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the Humoral Immune Protection Effect of VP60 Vaccine.
    Li Z; Song K; Du Y; Zhang Z; Fan R; Zheng P; Liu J
    Curr Issues Mol Biol; 2023 Aug; 45(8):6605-6617. PubMed ID: 37623236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative susceptibility of eastern cottontails and New Zealand white rabbits to classical rabbit haemorrhagic disease virus (RHDV) and RHDV2.
    Mohamed F; Gidlewski T; Berninger ML; Petrowski HM; Bracht AJ; de Rueda CB; Barrette RW; Grady M; O'Hearn ES; Lewis CE; Moran KE; Sturgill TL; Capucci L; Root JJ
    Transbound Emerg Dis; 2022 Jul; 69(4):e968-e978. PubMed ID: 34738741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant canine adenovirus type 2 expressing rabbit hemorrhagic disease virus VP60 protein provided protection against RHD in rabbits.
    Jiang Q; Yu Z; Liu JS; Kong DS; Guo DC; Quan CS; Li BT; Hu XL; Qu L
    Vet Microbiol; 2018 Jan; 213():15-20. PubMed ID: 29291998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
    Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
    Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.